english.prescrire.org > Prescrire International > N°2 - June 1992

n°2

June 1992

Issue Contents
Editorial

Four players

p.49-50

New Products


HA-1A monoclonal antibody solution for infusion

p.51-53

Storage conditions

p.52

Buprenorphine sublingual tablets

p.53-55

Towards "graduated" prescription of analgesics

p.54

Buprenorphine and addiction

p.55

Nalbuphine solution for injection, buprenorphine solution for injection

p.55-56

Vinorelbine solutions for injection

p.57-58

Lisuride tablets

p.59-60

Metronidazole topical gel

p.61-62

Vidarabine preparation for injection

p.62-63

Evaluating the efficacy of treatments for chronic active hepatitis

p.63

Alpha interferons in chronic active viral hepatitis B in adults

p.64-65

Alminoprofen: yet another NSAID for the treatment of dysmenorrhoea

p.66

How useful is naftidrofuryl?

p.66-67

Recommendations: pregnancy and prevention of hepatitis B

p.68

Adverse Effects


Interactions of fluoxetine with other psychotropic drugs

p.69-70

Thirteenth annual French pharmacovigilance meeting: cyproterone

p.70

Thirteenth annual French pharmacovigilance meeting: proxibarbal

p.70

Thirteenth annual French pharmacovigilance meeting: angiotensin-converting enzyme inhibitors

p.70

Thirteenth annual French pharmacovigilance meeting: nilutamide

p.70

Thirteenth annual French pharmacovigilance meeting: oral antidiabetic drugs

p.70

Thirteenth annual French pharmacovigilance meeting: anorectics and pregnancy

p.70

Thirteenth annual French pharmacovigilance meeting: ketoconazole and pregnancy

p.70

Little-known side-effects of neuroleptics

p.71-72

Epidemiology of gastrointestinal bleeding due to NSAIDs

p.72-73

Dangers of caffeine benzoate in paediatric use

p.73-74

Hepatitis due to the amoxicillin + clavulanic acid combination

p.74

Reviews


Gallstones: management should fit the individual patient

p.75-78

Patients must be informed

p.76

Further evaluation is required

p.77

NSAIDs are dangerous for the fetus in late pregnancy

p.79-81

Inhibitory action on prostaglandin synthesis

p.80

Keep an eye on the systemic adverse effects of topical ocular beta-blockers

p.81-83

Tienilic acid: flushed away at last!

p.84-86

Centoxin°: more evaluation wanted!

p.87

Hidden neuroleptics

p.88

Outlook


The pharmaceutical industry needs to pull its socks up!

p.89

Prevention of ulcer relapse

p.90

Orthodontic treatments

p.90-91

The disintegrating condom

p.91

Tailoring treatment of the menopause

p.91

Evaluating therapeutic devices

p.91-92

Inadequate clinical trials in Africa

p.92

Antidepressants in the elderly

p.92

Review of clinical trials in homeopathy

p.92-93

Laboratory results and pregnancy

p.93

Directions for essential drugs in developing countries

p.93

Investigating spa treatment

p.93

Frequency assessment of adverse effects: the case of spontaneous reporting

p.93

Forum


Acetylsalicylic acid and pregnancy

p.94

"packaging"

p.94

Mifepristone and virginity

p.94-95

Reasons for drug discontinuations

p.95

The complete contents of 
this issue of Prescrire International
are available for download by
Prescrire International subscribers.
Certain texts are also available to
non-subscribers for free download,
as indicated. 

 

Subscribe